Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
15.02
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
Mind Medicine, Allied Among Top Psychedelic Movers Of Today
↗
February 02, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17
Via
Benzinga
New Psychedelics ETF Launches On NYSE Arca
↗
February 02, 2022
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)...
Via
Benzinga
Mindset Pharma, Allied Among Top Psychedelic Movers Of Today
↗
February 01, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69
Via
Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
↗
January 31, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33
Via
Benzinga
MindMed Successfully Completes Phase 1 Trial Of 18-MC
↗
January 19, 2022
This article was originally published on Microdose...
Via
Benzinga
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
↗
January 30, 2022
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From January 28, 2022
↗
January 28, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57
Via
Benzinga
Bruce Linton's Óskare Capital Announces Strategic Cannabis Investment Partnership
↗
January 27, 2022
Óskare Capital, the life science and deep tech fund owned by renown investor Bruce Linton and Alpha Blue Ocean, a global investment firm, announced on Thursday the formation of a strategic partnership...
Via
Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
↗
January 27, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49
Via
Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
↗
January 26, 2022
GAINERS: Small Pharma (OTC:
Via
Benzinga
MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years
↗
January 26, 2022
MindMed (NASDAQ:MNMD), a drug development company in the p...
Via
Benzinga
51 Biggest Movers From Yesterday
↗
January 26, 2022
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...
Via
Benzinga
Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today
↗
January 25, 2022
GAINERS: Mind Medicine (NASDAQ:
Via
Benzinga
BNTX Stock Alert: The Omicron Vaccine News That Has BioNTech Shooting Higher Today
↗
January 25, 2022
BioNTech (BNTX) stock is rising higher on news it and Pfizer (PFE) can test a new Covid-19 vaccine for Omicron in adults.
Via
InvestorPlace
MNMD Stock: The FDA Go-Ahead That Has MindMed Investors Feeling Euphoric Today
↗
January 25, 2022
MindMed (MNMD) stock is getting a buzz today thanks to approval from the FDA to move forward with a clinical trial of MM-120.
Via
InvestorPlace
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jan. 25, 2022: MSFT, SHOP, ERIC, MNMD, TSLA
↗
January 25, 2022
Today's 5 Stock Ideas: Microsoft (MSFT) - The company reports Q2 earnings today after the close. Shopify (SHOP) - Shares down premarket. Keybanc lowered its price target...
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2022
↗
January 24, 2022
GAINERS: Field Trip Health (NASDAQ:
Via
Benzinga
Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri
↗
January 24, 2022
Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychede...
Via
Benzinga
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD
↗
January 23, 2022
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From January 21, 2022
↗
January 21, 2022
GAINERS: GH Research (NASDAQ:
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 20, 2022
↗
January 20, 2022
GAINERS: Small Pharma (OTC:
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
January 19, 2022
GAINERS: Revive Therapeutics (OTC:
Via
Benzinga
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
January 19, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of...
Via
FinancialNewsMedia
Psychedelic Stock Gainers And Losers From January 18, 2022
↗
January 18, 2022
GAINERS: Cybin (AMEX:
Via
Benzinga
MindMed Launches Study Using Monitoring System For Psychedelic Experiences
↗
January 18, 2022
Psychedelics biotech company MindMed (NASDAQ:MNMD) has enr...
Via
Benzinga
Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth
↗
January 10, 2022
Stephen Hurst Steps Down From MindMed's Board Of Directors Psychedelic-focused biotech company Mind Medicine Inc
Via
Benzinga
Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington
↗
January 10, 2022
Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov...
Via
Benzinga
Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High
↗
January 09, 2022
There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents.
Via
Talk Markets
A Recap of How Psychedelics Fared in 2021
January 07, 2022
Via
Investor Brand Network
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
↗
January 04, 2022
On Tuesday, Mind Medicine Inc. (NASDAQ:MNMD) (NEO: MM...
Via
Benzinga
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
